We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 23.36%
This Fund
S&P 500
This Quarter Est. Return
+0.44%
1 Year Est. Return
+23.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33K
AUM Growth
-$107M
Cap. Flow
-$107M
Cap. Flow %
-322,946.95%
Top 10 Hldgs %
100%
Holding
2,163
New
1
Increased
–
Reduced
1
Closed
2,153

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$418K
2
GIS icon
General Mills
GIS
+$355K
3
WMT icon
Walmart Inc
WMT
+$303K
4
K
Kellanova
K
+$292K
5
PEP icon
PepsiCo
PEP
+$277K

Sector Composition

Rank Sector Weight
1 Healthcare 9.09%
2 Consumer Discretionary 0%
3 Consumer Staples 0%
4 Energy 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESGR
476
DELISTED
Enstar Group
ESGR
– –
-150
Closed -$30K
ESI icon
477
Element Solutions
ESI
$9.12B
– –
-7,607
Closed -$96K
ESNT icon
478
Essent Group
ESNT
$6.06B
– –
-2,400
Closed -$89K
ESSA
479
DELISTED
ESSA Bancorp
ESSA
– –
-872
Closed -$13K
ET icon
480
Energy Transfer Partners
ET
$70.1B
– –
-2,689
Closed -$48K
ETN icon
481
Eaton
ETN
$157B
– –
-2,091
Closed -$163K
ETR icon
482
Entergy
ETR
$54.1B
– –
-400
Closed -$15K
EVC icon
483
Entravision Communication
EVC
$983M
– –
-3,296
Closed -$22K
EVR icon
484
Evercore
EVR
$13.1B
– –
-727
Closed -$51K
EVOK
485
DELISTED
Evoke Pharma
EVOK
– –
-17
Closed -$6K
EVRI
486
DELISTED
Everi Holdings
EVRI
– –
-3,191
Closed -$23K
EVTC icon
487
Evertec
EVTC
$1.83B
– –
-3,222
Closed -$56K
EW icon
488
Edwards Lifesciences
EW
$47.6B
– –
-2,400
Closed -$95K
EWBC icon
489
East-West Bancorp
EWBC
$17.9B
– –
-800
Closed -$47K
EXAS
490
DELISTED
Exact Sciences
EXAS
– –
-1,160
Closed -$41K
EXC icon
491
Exelon
EXC
$48.6B
– –
-1,682
Closed -$43K
EXEL icon
492
Exelixis
EXEL
$13.9B
– –
-2,009
Closed -$49K
EXK
493
Endeavour Silver
EXK
$2.32B
– –
-1,898
Closed -$6K
EXLS icon
494
EXL Service
EXLS
$4.23B
– –
-6,965
Closed -$77K
EXP icon
495
Eagle Materials
EXP
$6.6B
– –
-1,000
Closed -$92K
EXPD icon
496
Expeditors International
EXPD
$22.9B
– –
-400
Closed -$23K
EXTR icon
497
Extreme Networks
EXTR
$3.86B
– –
-5,140
Closed -$47K
EYPT icon
498
EyePoint Inc
EYPT
$1.02B
– –
-953
Closed -$16K
FAF icon
499
First American
FAF
$7.67B
– –
-2,696
Closed -$120K
FAST icon
500
Fastenal
FAST
$54B
– –
-6,428
Closed -$70K
18 19
20
21 22

Similar funds

CRAM
Claren Road Asset Management New York $891K AUM
ABFS
Appropriate Balance Financial Services Bellevue, Washington $2.01M AUM 19.83% 1-Year Est. Return
VHS
Vitol Holding (Switzerland) Geneva, Switzerland $4.12M AUM
ACM
Addison Clark Management Stamford, Connecticut $5M AUM 6.65% 1-Year Est. Return
SIM
Summitview Investment Management Grand Cayman, Cayman Islands $6.18M AUM
MC
Mitra Capital Boston, Massachusetts $10.2M AUM 51.14% 1-Year Est. Return
TU
Teilinger USA Houston, Texas $12.7M AUM
ASB
Amundi Smith Breeden Durham, North Carolina $18.8M AUM

Acrospire Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Acrospire Investment Management held 2,163 positions worth $33K, down 100% from $107M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Acrospire Investment Management withdrew a net $107M in Q3 2017, closing 2,153 positions and reducing 1 holding. Its most notable exit was Procter & Gamble, an estimated $418K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Acrospire Investment Management's biggest Q3 2017 reduction was Patheon N.V., cutting an estimated $3.49K.
  • Acrospire Investment Management fully exited Procter & Gamble in Q3 2017, selling an estimated $418K.
  • Acrospire Investment Management's ten largest holdings make up 100% of its $33K portfolio in Q3 2017.
  • Acrospire Investment Management opened 1 new position and closed 2,153 in Q3 2017.
  • Acrospire Investment Management's portfolio value fell 100% quarter-over-quarter to $33K.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.